Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details
Comparator and Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222 / MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis (Protocol No. MK-3222 011)
Clinical Trial ( IRB ) #: 14-029-3
Title: Comparator and Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222 / MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis (Protocol No. MK-3222 011)
Principal Investigator: Dr. Bruce Strober
Description: Study description not available
Classification:
  Skin
Eligibility Criteria: Check with study contact
How to Contact: Cheryl Martin. Telephone: (860) 679-2943. Email: Cmartin@uchc.edu
Enrollment Status/Comments: No longer enrolling.